These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Soft agar colony formation of bladder cells during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine and application to detection of bladder cancer promoters. Hashimura T; Kanamaru H; Yoshida O Jpn J Cancer Res; 1987 May; 78(5):473-9. PubMed ID: 3112059 [TBL] [Abstract][Full Text] [Related]
3. L-isoleucine and L-leucine: tumor promoters of bladder cancer in rats. Nishio Y; Kakizoe T; Ohtani M; Sato S; Sugimura T; Fukushima S Science; 1986 Feb; 231(4740):843-5. PubMed ID: 3945812 [TBL] [Abstract][Full Text] [Related]
4. L-Isoleucine and L-leucine are promoters of bladder cancer in rats. Kakizoe T; Nishio Y; Honma Y; Niijima T; Sugimura T Princess Takamatsu Symp; 1983; 14():373-80. PubMed ID: 6680728 [TBL] [Abstract][Full Text] [Related]
5. Lack of enhancing effect of mucosal regeneration following ulceration of the urinary bladder on N-butyl-N-(4-hydroxybutyl)nitrosamine carcinogenesis in rats. Shirai T Cancer Res; 1980 Oct; 40(10):3709-12. PubMed ID: 7438054 [TBL] [Abstract][Full Text] [Related]
6. Agglutination of bladder cells by concanavalin A during the early phase of treatment of rats with N-butyl-N-(4-hydroxybutyl)nitrosamine. Kakizoe T; Kawachi T; Sugimura T Cancer Res; 1979 Sep; 39(9):3353-6. PubMed ID: 476666 [TBL] [Abstract][Full Text] [Related]
7. Correlation of results of agglutination assays with concanavalin A and carcinogenesis experiments on promoters of bladder cancer. Kakizoe T; Nishio Y; Ohtani M; Niijima T; Sato S; Sugimura T Jpn J Cancer Res; 1985 Oct; 76(10):930-6. PubMed ID: 3935624 [TBL] [Abstract][Full Text] [Related]
8. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats. Miyata Y; Fukushima S; Hirose M; Masui T; Ito N Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281 [TBL] [Abstract][Full Text] [Related]
9. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice. Irving CC; Murphy WM; Daniel DS J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920 [TBL] [Abstract][Full Text] [Related]
10. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer. Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741 [TBL] [Abstract][Full Text] [Related]
11. Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats. Cohen SM; Ellwein LB; Okamura T; Masui T; Johansson SL; Smith RA; Wehner JM; Khachab M; Chappel CI; Schoenig GP Cancer Res; 1991 Apr; 51(7):1766-77. PubMed ID: 2004360 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory action of alpha-difluoromethylornithine on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis. Uchida K; Seidenfeld J; Rademaker A; Oyasu R Cancer Res; 1989 Oct; 49(19):5249-53. PubMed ID: 2504487 [TBL] [Abstract][Full Text] [Related]
13. Urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)-nitrosamine in an analbuminemic congenic strain of rats with an ACI genetic background. Nagase S; Shumiya S; Takahashi M; Maekawa A; Hayashi Y Jpn J Cancer Res; 1986 Dec; 77(12):1198-200. PubMed ID: 3102424 [TBL] [Abstract][Full Text] [Related]
14. [The lithium carbonate promotion of urothelial tumors in rats induced with N-butyl-N-(4-hydroxybutyl)-nitrosamine]. Frolov AG; Pliss GB Vopr Onkol; 1992; 38(11):1309-13. PubMed ID: 1343160 [TBL] [Abstract][Full Text] [Related]
15. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis. Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018 [TBL] [Abstract][Full Text] [Related]
16. [Effect of intravesical instillation of the antitumor chemotherapeutic agents mitomycin C and cytosine arabinoside on rat bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine]. Inoue K; Okamura T; Fukushima S; Ito N; Ohtaguro K Gan To Kagaku Ryoho; 1987 Jan; 14(1):71-6. PubMed ID: 3099653 [TBL] [Abstract][Full Text] [Related]
17. Possible mechanistic roles of anatomical and functional vascular changes in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Tatematsu M; Lurie AG; Rippey RM; Conran PB; Arai M; Fukushima S; Ito N Cancer Res; 1984 Jan; 44(1):278-84. PubMed ID: 6690039 [TBL] [Abstract][Full Text] [Related]
18. [Effect of cis-diamminedichloroplatinum (II) (CDDP) on bladder cancer on rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)]. Miyakawa M; Yoshida O Gan To Kagaku Ryoho; 1982 Feb; 9(2):258-62. PubMed ID: 6820893 [TBL] [Abstract][Full Text] [Related]
19. [Failure to activate Epstein-Barr virus genome in a latently-infected human lymphoblastoid cell line with urine containing a bladder carcinogenesis promoter]. Fujita J; Yoshida O Hinyokika Kiyo; 1984 Jul; 30(7):897-901. PubMed ID: 6095626 [TBL] [Abstract][Full Text] [Related]
20. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Kitahori Y; Konishi N; Shimoyama T; Hiasa Y Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]